Post by Curia

Reflecting on a successful #CPHIChina 2026. Thank you to our customers, partners and colleagues who joined us to discuss the evolving API landscape in China. China continues to be a strategic market for Curia, and we are proud of the strong track record we've built. Our portfolio of APIs approved for the Chinese market spans a wide range of therapeutic areas. Backed by decades of experience in complex regulatory environments, Curia is your trusted partner to ensure successful regulatory outcomes and facilitate smooth market access. Explore our full catalog here: https://hubs.li/Q04prF-M0 #Curia #SmallMolecule #APIManufacturing